LRMR logo

Larimar Therapeutics, Inc. Common Stock


LRMR: Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.


Show LRMR Financials

Consumer Interest
SEC Filings

Recent trades of LRMR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by LRMR's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of LRMR in WallStreetBets Daily Discussion


Recent insights relating to LRMR

CNBC Recommendations

Recent picks made for LRMR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LRMR

Corporate Flights

Flights by private jets registered to LRMR